F ull-thickness cartilage defects are associated with knee pain and mechanical symptoms and are predictors of endstage osteoarthritis 1, 2 . Several surgical methods, including microfracture, osteochondral autograft transplantation, and autologous chondrocyte implantation (ACI), have been used to provide fibrocartilage or hyaline cartilage to the defect sites [3] [4] [5] [6] . Although these methods restore cartilage integrity, there is a paucity of data on their protective effect with regard to pain and osteoarthritis progression [3] [4] [5] [6] . Among all of these methods, ACI and especially matrix-associated ACI (MACI) have been considered to be promising modalities to provide viable chondrocytes to a large articular injured area, with favorable clinical outcomes 3, 7, 8 . To perform a standard ACI or MACI, chondrocytes are initially harvested arthroscopically from a non-weight-bearing cartilage surface region (e.g., the medial or lateral trochlear ridge or the femoral intercondylar notch) [9] [10] [11] . The harvested samples are cultured on a collagen membrane and then are implanted into the defect via a second arthrotomy or arthroscopic surgery 9, 10 . Despite the positive experiences that have been reported in association with ACI and MACI, these methods have numerous limitations, including hypertrophy and overgrowth of the periosteal patch, unpredictable long-term chondrocyte viability, and extraordinary cost 12 . The requirement for 2 consecutive operations can limit the clinical application of ACI because of the morbidity and complications associated with these procedures 13, 14 . Image-guided tissue harvesting is a well-established minimally invasive procedure that has been primarily used for the diagnosis of bone and soft-tissue abnormalities 15, 16 . This method currently is performed with use of computed tomography (CT), ultrasound, and magnetic resonance imaging (MRI) in the outpatient setting, and it is feasible and comparable with open biopsy in terms of costs, complications, and patient satisfaction 17, 18 . The purpose of the present study was to investigate the feasibility of image-guided chondrocyte harvesting as an alternative to arthroscopic surgery for the first stage of ACI or MACI. The present investigation was performed in 2 parts. In the first part, a human cadaveric study was performed to assess the feasibility and accuracy of image-guided chondrocyte harvesting with use of CT arthrography (CTA) as well as to evaluate the accuracy of CTA in determining the diameters of cartilage defects. In the second part, a pilot clinical study was performed to investigate the quantity and quality of obtained chondrocytes.
Materials and Methods

Study Samples
W e obtained 10 human cadaveric lower extremities in accordance with Health Insurance Portability and Accountability Act (HIPAA) recommendations. Full-thickness cartilage defects (average height and width, 18.3 and 12.4 mm, respectively) were induced in all specimens, and CTA-guided needle chondrocyte harvesting was performed as described below.
For the institutional review board-approved, HIPAAcompliant clinical study, 10 human subjects were recruited from an orthopaedic sports medicine clinic between January 2015 and January 2016. As part of the informed-consent process, all subjects were informed about the 2 applied methods of chondrocyte harvesting. All 10 subjects had full-thickness cartilage defects and were candidates for standard ACI, and all underwent same-day needle harvesting and conventional arthroscopic retrieval of chondrocytes.
Introducing Full-Thickness Cartilage Defects (Cadaveric Study) An arthrotomy was performed with use of a medial parapatellar approach 19 . The incision was made from 5 cm above the superior patellar margin to the tibial tubercle in a curvilinear fashion. Articular cartilage in the femoral epiphysis was inspected in 3 locations (the trochlea, medial femoral condyle, and lateral femoral condyle). At each site, 1 full-thickness cartilage defect was induced with use of straight and curved microcurets. The cartilage defects had distinct margins. In 1 sample, the medial condylar cartilage had a large full-thickness cartilage defect, and no additional injury was induced in that location. In another sample, the lateral condylar cartilage was completely denuded, and we were not able to create any defect at that site. The height and width of the cartilage defects were measured by an observer who was not involved in the CTA measurements; the average height was 18.3 mm (range, 11 to 42 mm), and the average width was 12.4 mm (range, 5 to 38 mm). The joint capsule, fascia, and skin were then closed. CTA and CTA-Guided Needle Harvesting (Cadaveric Study) Following the creation of the cartilage defects, CTA and CTAguided chondrocyte harvesting were performed on all cadaveric knees. All scans were performed with use of a Siemens CTscanner (Siemens Medical Systems) according to CT parameters that are routinely used in clinical practice (120 kVp and 150 to 200 mA).
First, preprocedural CT acquisition was performed and the target site for performing chondrocyte retrieval was marked and recorded ( Fig. 1) . Next, following the intra-articular administration of 20 mL of Omnipaque 350 (Nycomed), CTA was performed to visualize the joint space and the fullthickness cartilage defects ( Fig. 1 ). Multiplanar reconstructions of the scanned data were examined on a picture archiving and communication system (Emageon Workstation; Emageon). After image acquisition, a musculoskeletal radiologist with 8 years of clinical experience reviewed and measured the height and the width of the cartilage defects (in millimeters) on CTA.
Subsequently, the specimens underwent CTA-guided chondrocyte harvesting. An Osteo-Site bone biopsy needle (product number, G13761; description, Murphy M1M; size, 11 gauge · 10 cm) was used for chondrocyte retrieval (Fig. 2 ). Two operators (1 musculoskeletal radiologist and 1 orthopaedic surgeon) performed the procedures. Each operator performed 1 sampling from the medial ridge of the trochlea and 1 sampling from the lateral ridge. Time (in seconds), accuracy (the distance [in millimeters] between the predefined target on the preprocedural CT scan and the final insertion site of the needle) ( Fig. 1) , and the number of needle readjustment attempts were recorded.
Chondrocyte Retrieval with Use of Standard Arthroscopic Versus Needle Harvesting (Clinical Study) Cartilage samples were obtained arthroscopically from a nonweight-bearing area on the femoral intercondylar notch of the damaged knee with use of the conventional technique to ensure the standard of care regarding the adequacy of samples for planned ACI 9, 10 . Simultaneously during the routine arthroscopic chondrocyte retrieval, an Osteo-Site coaxial bone biopsy needle set (product number, G13761; description, Murphy M1M; size, 11 gauge · 10 cm; M2-S) was inserted through the arthroscopy probe access site to obtain additional chondrocytes from the non-weight-bearing lateral trochlear ridge. The retrieved samples were placed in a sterile medium and were submitted for cell culture separately.
Isolation and Culture of Chondrocytes (Clinical Study)
In vitro culture of the obtained cells was performed with use of the method described by Brittberg et al. 10 . The cartilage specimens were washed, and adherent bone and synovial tissue were removed. The weights of the samples were recorded (mg), and the samples were then minced and digested in the culture medium. The obtained cells were then filtered through a nylon mesh (pore diameter, 25 mm) and were counted. The derived Image-Guided Chondrocyte Harvesting for Autologous Chondrocyte Implantation cells were transferred and cultured, and the number of cells per sample weight (cells/mg), the total number of viable chondrocytes (number of cells), and the cellular growth index (doublings/day) were calculated.
Statistical Analysis
First, in the cadaveric study, the accuracy of CTA in measuring the diameters of the cartilage defects was evaluated. CTA measurements were compared with the direct visual measurements of cartilage lesions, and interclass correlation coefficients (ICCs) were calculated to evaluate the absolute agreement and consistency.
Second, also in the cadaveric study, the accuracy and feasibility of CTA-guided chondrocyte harvesting were determined. The time required to obtain tissue (sec), accuracy (mm), and number of needle readjustments were compared with use of the t test (for normally distributed variables) or the Mann-Whitney U test (for non-normally distributed values) between samplings from the medial and lateral trochlear ridges. Similarly, the variables were compared between the 2 operators.
Third, in the clinical study, the quantity and quality of samples retrieved with use of the needle-harvesting and conventional methods were compared. With use of the paired t test (for normally distributed values) or the paired Wilcoxon signedrank test (for non-normally distributed values), the weight (total, net, and processed), number of cells, and growth index of samples were compared for each patient.
A 2-tailed p value of <0.05 was considered significant. Analyses were performed with use of the R platform (version 3.2.5; R Foundation for Statistical Computing) and SPSS (version 24; IBM).
Results
C
TA measurements of full-thickness cartilage defects had high to perfect absolute agreement and consistency with regard to the direct visual measurements (overall ICC, 0.933 to 0.983). The width of the lateral femoral condyle was an exception in our experiment (ICC, 0.404), possibly due to the low sample size and the exclusion of 1 knee with a completely denuded lateral femoral condyle. CTA also showed high accuracy: the differences between CTA-derived and direct visual measurements ranged from 0 to 2 mm. Table I summarizes the CTA performance in estimating the full-thickness cartilage defects.
CTA-guided chondrocyte harvesting resulted in successful cartilage retrieval in each case. There were no significant differences between the 2 operators in terms of time, the accuracy of performance, or the number of needle readjustments (p > 0.05). For each operator, sampling from the lateral trochlear ridge was more accurate (p = 0.007 and 0.040) and faster (p = 0.056 and 0.014) when compared with sampling from the medial trochlear ridge. The clinical study showed that a greater amount of tissue (in terms of weight) and a higher number of viable cells were obtained with use of the conventional arthroscopic technique in comparison with needle harvesting (Table III) . However, there was no significant difference between 2 methods in terms of the cellular growth index (p = 0.897) (Table III) .
Discussion
I n the present study, we showed that image-guided chondrocyte harvesting might be a feasible method for viable chondrocyte retrieval. We also demonstrated that CTA could be used for accurate assessment of full-thickness cartilage defects. We recognize the current pivotal role of arthroscopic biopsy, as a part of ACI, for chondrocyte harvesting as well as for delineating the nature of the lesion. However, our results suggest that image-guided chondrocyte retrieval may obviate the need for arthroscopic biopsy in some patients in the future.
MACI is indicated and performed for symptomatic patients with isolated 2 to 10-cm 2 full-thickness cartilage defects of the knee, without any specific age cutoff. In the present study, we tested the hypothesis that an image-guided procedure may be an alternative for arthroscopic chondrocyte retrieval for MACI or ACI, with the possibility of lower overall cost as well as lower rates of complications and morbidity 15, 20 . Image-guided biopsy has been recognized as a minimally invasive, accessible, and feasible technique, with an accuracy comparable with that of open biopsy, which is currently used in clinical practice for the diagnosis of musculoskeletal tumors and infection [15] [16] [17] [18] [19] [20] [21] 22 . For the first time, we showed that image-guided chondrocyte harvesting is a feasible and accurate method for cartilage sampling when performed by both a radiologist and an orthopaedic surgeon 14 . In the present study, CTA-guided harvesting was performed on the medial and lateral trochlear ridges, which are the recommended sites of cartilage retrieval for ACI 12, 23 . No sample was harvested from the femoral intercondylar notch (the most common site for conventional arthroscopic chondrocyte retrieval), which was not accessible with use of cross-sectional image-guided approaches. We found that all attempts resulted in successful tissue retrieval. In addition, sampling from the lateral trochlear ridge was faster and more accurate in comparison with sampling from the medial trochlear ridge. We also investigated the adequacy, quality, and viability of the retrieved chondrocytes in a clinical setting. In order to create an MACI membrane, previous investigators have recommended harvesting a specimen containing 200 mg of healthy cartilage 12, 23 . Chondrocytes are then isolated from the harvested sample and are seeded on type-I and III collagen membrane at a density of >500,000 cells/square cm 12, 23 . Despite the lower amount of tissue yielded through our needle-harvest method (with the average weight of harvested samples from a single needle biopsy attempt being 101 mg, which was lower than the required 200 mg), samples obtained with use of the needle showed comparable quality and viability. Our results showed total number of 5,000,000 cells were obtained using needle harvest method which was adequate for creating MACI membrane 12, 23 . Two or more samples using image-guided chondrocyte harvesting may be required for optimal result in subjects with large and/or multiple cartilage defects.
The use of CTA as an accurate imaging modality for the assessment of cartilage defects has been suggested by previous investigators [24] [25] [26] [27] . In human cadaveric studies, Vande Berg et al. and Li et al. reported overall correlation coefficients of 0.8 when cartilage defects were evaluated with use of CTA and direct visual measurements 25, 28 . De Filippo et al., in a clinical study, found that CTA had an accuracy of 92% to 95% and perfect interobserver agreement (kappa = 0.97) for the diagnosis of cartilage defects 29 . Our findings also demonstrated that CTA measurements had excellent accuracy (overall ICC, 0.828 to 0.997). Arthroscopy has been considered to be the goldstandard tool for the assessment of articular damage 30, 31 . Several studies have demonstrated that estimating the exact diameters of cartilage defects is challenging and that imaging modalities may result in underestimation or overestimation of the size of defects when compared with arthroscopy [32] [33] [34] [35] . Gomoll et al. showed that the size of cartilage defects was underestimated by 65% when MRI measurements were compared with direct measurements 36 . In contrast, the high accuracy of imaging methods for estimating the exact diameters of articular lesions has been demonstrated in a handful of prior studies 28, 32, 34, [37] [38] [39] . Recent advances have led to marked improvement in the determination of cartilage defect size with use of both highresolution MRI and CTA 37, 40 . On the basis of our initial experience in the present study, advanced imaging techniques such as CTA and MRI can be considered as noninvasive alternatives that can obviate the need for arthroscopy for both viable chondrocyte retrieval and the measurement of cartilage defects as part of ACI. However, arthroscopic procedures are valuable for evaluating the size of cartilage defects as well as for chondrocyte harvesting for ACI. Given the current pivotal role of arthroscopy in ACI, it would not be appropriate to perform ACI chondrocyte retrieval on the basis of imaging only. Additional studies are needed to answer the question of whether image-guided chondrocyte retrieval may obviate the need for arthroscopic surgery in some patients. It also should be noted that we only evaluated the role of CTA (not MRI) with a high radiation dose as an alternative method for arthroscopy since we performed both defect size measurements and sampling simultaneously. On the other hand, in comparison with MRI, CTA is a feasible and low-cost method that is widely accessible in most centers. In routine clinical practice, most patients with knee osteoarthritis are evaluated with MRI before undergoing ACI; therefore, we can potentially perform non-enhanced CT-guided tissue harvest and can measure the size of cartilage defects with use of available MRI.
The present study had some limitations. First, is possible that the use of cadaveric knees had an impact on the results because of differences between the cadaveric and normal knees (e.g., lack of normal articular fluid or subject motion during the intervention). Second, in the clinical portion of the study, CTAguided chondrocyte harvesting was not conducted and needle harvest was performed during the standard arthroscopic procedure. With regard to these limitations, it should be noted that the current study was the first feasibility study, to our knowledge, that has evaluated the efficacy of image-guided chondrocyte harvesting and that more clinical evidence is needed to establish all aspects of this new method. Third, we only assessed the role of CT, which is associated with a high radiation dose. On the other hand, CTA does not show compositional cartilage abnormalities; therefore, preprocedural high-resolution MRI assessment can be an important step in the evaluation of overall cartilage status in terms of both defect size and the determination of the optimum target site for chondrocyte harvest. Also, as a result of recent advances, MRI-guided procedures (e.g., magnetic resonance arthrography [MRA]) could be a feasible alternative to CTAguided procedures for real-time monitoring of the injection of contrast medium and chondrocyte harvest. It also has been suggested that MRI and MRA can precisely determine defect size in a fashion similar to CTA 26, 28 . Thus, we believe that similar studies should be performed to evaluate the accuracy and feasibility of MRI-guided chondrocyte harvesting.
Image-guided chondrocyte harvesting may be a feasible and accurate method for viable chondrocyte retrieval. The current study can provide the platform for a prospective clinical trial to demonstrate the effectiveness of image-guided chondrocyte harvesting in selected patients with use of advanced CT or MRI guidance. n
